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Objective: Test the hypothesis that greater baseline peak external knee adduction moment (KAM), KAM
impulse, and peak external knee ﬂexion moment (KFM) during the stance phase of gait are associated
with baseline-to-2-year medial tibiofemoral cartilage damage and bone marrow lesion progression, and
cartilage thickness loss.
Methods: Participants all had knee OA in at least one knee. Baseline peak KAM, KAM impulse, and peak
KFM (normalized to body weight and height) were captured and computed using a motion analysis
system and six force plates. Participants underwent MRI of both knees at baseline and 2 years later. To
assess the association between baseline moments and baseline-to-2-year semiquantitative cartilage
damage and bone marrow lesion progression and quantitative cartilage thickness loss, we used logistic
and linear regressions with generalized estimating equations (GEE), adjusting for gait speed, age, gender,
disease severity, knee pain severity, and medication use.
Results: The sample consisted of 391 knees (204 persons): mean age 64.2 years (SD 10.0); BMI 28.4 kg/
m2 (5.7); 156 (76.5%) women. Greater baseline peak KAM and KAM impulse were each associated with
worsening of medial bone marrow lesions, but not cartilage damage. Higher baseline KAM impulse was
associated with 2-year medial cartilage thickness loss assessed both as % loss and as a threshold of loss,
whereas peak KAM was related only to % loss. There was no relationship between baseline peak KFM and
any medial disease progression outcome measures.
Conclusion: Findings support targeting KAM parameters in an effort to delay medial OA disease
progression.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.: A.H. Chang, Department of
einberg School of Medicine,
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Osteoarthritis (OA) is a leading contributor to chronic disability1.
Twenty-three percent of US adults report doctor-diagnosed
arthritis and 10% have arthritis-related activity limitations2. OA is
the most common form of arthritis, frequently affecting the knee.
The impact of knee OA in the US is likely to increase due to the aging
population, obesity epidemic, and paucity of disease-modifying
treatment. It is well accepted that an abnormal knee local me-
chanical environment can contribute to joint damage. Change in
medial-to-lateral tibiofemoral load distribution and greater medial
load are theorized to increase the risk of medial knee OA disease
progression3.td. All rights reserved.
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gold standard method for measurement of medial knee load, but it
is invasive and impractical. Knee load cannot be directly measured
in vivo noninvasively. The external knee adduction moment (KAM)
during the stance phase of gait has been characterized both as a
determinant and a surrogate for dynamic medial knee load3,4. KAM
reﬂects the medial-to-lateral joint load distribution5 and has been
associated with lower limb varus alignment6, medial OA disease
severity7, and medial-to-lateral bone mineral density ratio8. Efforts
have been directed toward developing and testing interventions
that lower KAMwith the ultimate goal of modifying disease course
in medial tibiofemoral OA9,10. However, longitudinal evidence of an
association between baseline KAM and subsequent medial disease
progression comes from only a few studies with inconsistent
ﬁndings11e13.
Peak KAM during the stance phase potentially captures maximal
medial joint load experienced at any one instant of time. KAM
impulse is the time integral of KAM over the stance phase. By
incorporating both load magnitude and duration, KAM impulse
may provide a cumulative measure of KAM sustained during each
step of walking. There is a theoretical rationale to support a role for
both of these parameters in disease progression. Studies in recent
years suggest that a reduction in KAM may be accompanied by a
deleterious increase in the external knee ﬂexion moment
(KFM)14,15. However, whether KFM plays a role in knee OA disease
progression in OA knees is unclear.
The objective of this study was to evaluate the association be-
tween baseline KAM and KFM parameters and subsequent medial
tibiofemoral OA disease progression over 2 years. We hypothesized
that in persons with knee OA, greater baseline peak KAM, KAM
impulse, and peak KFM (each normalized to body weight and
height) during the stance phase of gait are each associated with
baseline-to-2-year worsening of medial tibiofemoral cartilage
damage and bone marrow lesions, and with quantitatively
measured cartilage thickness loss.
Methods
Sample
In this prospective, longitudinal, observational cohort study of
knee OA, the MAK-3 Study (Mechanical Factors in Arthritis of the
Knee-Study 3), participants were recruited from the community
using advertising in periodicals, neighborhood organizations, let-
ters to the Buehler Center on Aging, Health, and Society registry at
Northwestern University, and viamedical center referrals. Inclusion
criteria were: deﬁnite tibiofemoral osteophyte presence [Kellgren/
Lawrence (K/L) radiographic grade  2] in one or both knees; and
Likert category of at least “a little difﬁculty” for 2 or more items in
the WOMAC physical function scale. Exclusion criteria were:
corticosteroid injection within previous 3 months; avascular ne-
crosis, inﬂammatory arthritis, periarticular fracture, Paget's disease,
villonodular synovitis, joint infection, ochronosis, neuropathic
arthropathy, acromegaly, hemochromatosis, gout, pseudogout,
osteopetrosis, or meniscectomy; or MRI exclusions. Approval was
obtained from the Institutional Review Boards of Northwestern
University and NorthShore University HealthSystem Evanston
Hospital. All participants provided written consent.
Quantitative gait analysis
Kinematic data were collected at 120 Hz, using an 8-camera,
Eagle Digital Real-Time motion measurement system from Motion
Analysis Corporation (MAC). At a sampling rate of 960 Hz, ground
reaction forces and moments were measured with six AMTI(AdvancedMechanical Technology Inc., Watertown, MA, USA) force
platforms embedded ﬂush with the ﬂoor as participants walked
along a 10.7  1.2 m walkway. An experienced technician placed
external passive reﬂectivemarkers, using themodiﬁed Helen Hayes
full-body marker set16 (bilaterally on acromion process tip, lateral
humeral epicondyle, between radius and ulna styloids, anterior
superior iliac spine, superior sacrum at L5/sacral interface, lower
thigh, along ﬂexion/extension rotation axis at lateral femoral
condyle, lower leg, along ﬂexion/extension rotation axis at lateral
malleolus, posterior calcaneus, foot center between second and
third metatarsals). To closely match usual daily walking, each
participant wore his/her own comfortable athletic or walking shoes
and walked at a self-selected comfortable speed without using
assistive devices (no participant habitually used assistive devices).
A minimum of ﬁve trials having clean foot strikes on the force
platforms for the left and right feet were acquired, with rest be-
tween trials. OrthoTrak gait analysis software (MAC) was used to
calculate 3-D joint angles, moments, and temporalespatial pa-
rameters. Inverse dynamics were used to compute 3-D external
joint moments. Baseline predictors of peak KAM (% body weigh-
t*height), KAM impulse e the area under the KAM-time curve
(seconds*% body weight*height), and KFM (% body weight*height)
were calculated using custom Matlab programs. Gait speed was
measured within the quantitative gait analysis; the 5-trial average
was used.
While KAM normalization is widely accepted and established, to
address the possibility that the absolute (i.e., non-normalized) KAM
parameter values differed in pattern of association with the out-
comes, we evaluated the correlation between normalized and non-
normalized values, and, in sensitivity analyses, the association be-
tween non-normalized KAM parameters and outcomes.
MRI acquisition and semi-quantitative assessment of cartilage
damage and bone marrow lesion progression
At baseline and 2-year follow-up, magnetic resonance images
(MRI) of both knees were obtained in all participants, using a
commercial knee coil and 1 of 2 whole-body scanners, 3T Verio or
1.5T Avanto (both Siemens Healthcare, Erlangen, Germany); the
same scanner was used at both evaluations. The protocol included
coronal T1-weighted spin-echo (SE) [TR/TE/FOV/Matrix/Slice
thickness ¼ 3 s/20 ms/14 cm, 256  256, 3 mm at 3T; TR/TE/FOV/
Matrix/Slice thickness¼ 3 s/18ms/14 cm, 256 256, 3 mm at 1.5T],
and sagittal axial, and coronal fat-suppressed proton density-
weighted turbo spin echo sequences [TR/TE/Turbo Factor/FOV/
Matrix/Slice thickness ¼ 500 ms/11 ms/7/12 cm, 320  320, 3 mm
at 3T; TR/TE/Turbo Factor/FOV/Matrix/Slice thickness ¼ 600 ms/
11 ms/7/12 cm, 320  320, 3 mm at 1.5T].
Following a detailed reading protocol, each knee was scored
using the Whole-Organ MRI Score (WORMS) method17, by one of
two expert musculoskeletal radiologists. Baseline and 2-year scans
were evaluated as pairs, with known chronology as suggested for
longitudinal studies in knee OA18, but blinded to all other data. Two
medial weightbearing femoral condylar subregions (central and
posterior) and three medial tibial plateau subregions (anterior,
central, and posterior) were each scored separately for cartilage
morphology and bone marrow lesions. At each subregion, cartilage
morphologywas scored: 0 (normal thickness and signal); 1 (normal
thickness, increased signal on T2-weighted images); 2 (solitary,
focal, partial or full-thickness defect  1 mm in width); 3 (multiple
areas of partial-thickness loss or grade 2 lesion > 1 mm, with areas
of preserved thickness); 4 (diffuse, >75%, partial-thickness loss); 5
(multiple areas of full-thickness loss, or full-thickness
lesion > 1 mm, with areas of partial-thickness loss); and 6
(diffuse, >75%, full-thickness loss). Subchondral bone marrow
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(moderate, 25e50% of region); and 3 (severe, >50% of region). In a
previous study, the inter-rater intra-class correlation coefﬁcients
(ICCs) (unspeciﬁed model) for these same readers were 0.98 and
0.90 for medial cartilage morphology and bone marrow lesions
respectively17.
Baseline-to-2-year progression of cartilage damage and bone
marrow lesions in the medial tibiofemoral compartment were each
deﬁned as a full-grade score worsening in any of the ﬁve medial
femoral and tibial subregions. Medial femoral surface progression
was deﬁned as score worsening in either of the two femoral sub-
regions, and tibial surface progression as worsening in any of the
three tibial subregions.
Quantitative measurement of cartilage thickness loss
For the quantitative cartilage measurement, coronal spoiled
gradient echo sequences with water excitation were acquired, with
a slice thickness of 1.5 mm and an in-plane resolution of 0.31 mm
(ﬁeld of view 16 cm, 512 _ 512-pixel matrix, number of excitations
1). The repetition time, echo time, and ﬂip angle, respectively, were
18.6 ms/9.3 ms/15 on the 1.5T, and 12.2 ms/5.8 ms/9 on the 3T
scanner; baseline and follow-up acquisitions were always done
using the same magnet. The total area of subchondral bone and the
area of the cartilage surface were segmented in the medial tibial
surfaces, and in the weight-bearing portion of the medial femoral
condyles using proprietary software (Chondrometrics, Ainring,
Germany)19e22.
Average thickness of cartilage, including areas of denuded sub-
chondral bone as 0 mm, was quantiﬁed in baseline and 2-year
images with chronology known18. Using the same methodology,
cartilage thickness precision error (coefﬁcient of variation [CV] for
two acquisitions with repositioning) was 2.1% for the medial tibia
and 3.0% for the medial weightbearing femur19. The regions of in-
terest (ROI) in this study were the entire medial tibial and central
weightbearing femoral surfaces; external, central, and posterior
tibial subregions and external and central femoral subregions22,
since greater 12-month cartilage thinning and standardized
response means were observed in these than other subregions23.
Disease progression outcome in each ROI was analyzed as a
continuous outcome variable expressed as % cartilage loss over the
baseline-to-2 year follow-up period, and secondarily as a dichoto-
mous variable deﬁned as baseline-to-2-year cartilage thickness loss
5% (i.e., approximately twice the CV, as previously deﬁned19, a
threshold that is unlikely to reﬂect measurement error).
Assessment of disease severity, alignment, knee pain, and
medication use
All participants underwent bilateral, anteroposterior, weight-
bearing knee radiographs at baseline in the semi-ﬂexed position
with ﬂuoroscopic conﬁrmation of superimposition of the anterior
and posterior tibial plateau lines and centering of the tibial spines
within the femoral notch24. Disease severity was assessed using the
K/L system, 0 (normal), 1 (possible osteophytes), 2 (deﬁnite
osteophytes, with possible joint space narrowing), 3 (moderate
osteophytes with deﬁnite joint space narrowing, some sclerosis,
and possible attrition), and 4 (large osteophytes with marked joint
space narrowing, severe sclerosis, and deﬁnite attrition)25. To
assess knee alignment, a single anteroposterior radiograph of both
limbswas obtained using a 1.3 by 0.4-m graduated-grid cassette. All
radiographs were obtained in the same unit by two trained tech-
nicians. Alignment was measured as the angle formed by the
intersection of the line connecting the centers of the femoral head
and intercondylar notch with the line connecting the centers of thesurface of the ankle talus and tips of the tibial spines. Alignment
was recorded as negative for the varus direction, 0 for neutral, and
positive for valgus. Image analysis26 was completed by one of the
three trained readers using a customized program (Surveyor 3;
OAISYS Inc, Kingston, Ontario, Canada), blinded to all other data. In
a reliability study of 200 fullelimb pairs assessed by these readers,
the inter- and intra-reader ICCs were 0.95 and 0.9627.
Knee pain severity was measured using the Intermittent and
Constant Osteoarthritis Pain (ICOAP), a valid and reliable multidi-
mensional measure designed to comprehensively evaluate the pain
experience in knee or hip OA28,29. Medication use was deﬁned as a
yes answer to: During the past 30 days, have you used any of the
following medications for joint pain or arthritis on most days? (For
at least one category among acetaminophen, non-prescription
NSAIDs, prescription NSAIDs, and prescription pain medications.)
Statistical analysis
To assess the relationships between baseline peak KAM, KAM
impulse, and peak KFM (each as a continuous variable) and sub-
sequent cartilage damage and bone marrow lesion progression
(dichotomous outcomes) in the medial tibiofemoral compartment
and at femoral and tibial surfaces, we used logistic regression with
generalized estimating equations (GEE) to account for the corre-
lation between the two limbs of each individual, adjusting for gait
speed, age, gender, disease severity, knee pain severity, and medi-
cation use. Results are reported as odds ratios (ORs) and 95% con-
ﬁdence intervals (CIs). Similarly, linear and logistic regression
models with GEE methods were used to assess the relationships
between baseline peak KAM, KAM impulse, and peak KFM and
quantitative cartilage thickness loss outcomes. In sensitivity ana-
lyses, we used the same models with non-normalized KAM
parameters.
Results
Among 250 participants, 212 completed the 2-year follow-up
visit. Reasons for not completing included: participant not reach-
able (n ¼ 12); serious medical condition (n ¼ 6); too busy (n ¼ 5);
work (n ¼ 5); other (n ¼ 10). An additional eight participants
developed a contraindication or declined the follow-up MRI.
Among the remaining 204 participants (408 knees), 14 knees were
excluded due to a total knee replacement and three knees had
technical image problems, leaving the ﬁnal analysis sample of 391
knees from 204 participants. The mean age of the 204 participants
was 64.2 (SD 10.0) years, mean BMI was 28.4 (5.7) kg/m2, and 156
(76.5%) were women. Mean knee mechanical axis was 1.0 (4.0)
degrees (i.e., in the varus direction). The K/L grade distributionwas:
grade 0, 17 knees (4.3%); grade 1, 72 (18.4%); grade 2, 186 (47.6%);
grade 3, 56 (14.3%); and grade 4, 60 knees (15.4%). Mean gait speed
was 1.2 (0.2) m/s. Mean pain severity score was 9.24 (7.58) and 92
persons (45.1%) were taking medication on most of the past 30
days. Mean baseline peak KAM, KAM impulse, peak KFM were 1.67
(0.85) % body weight*height, 0.60 (0.44) seconds*% body weigh-
t*height, and 2.09 (0.85) % body weight*height respectively. Par-
ticipants who did not complete the follow-up did not differ from
completers in KAM, KAM impulse, gender, BMI, knee alignment, K/L
grade, and medication use. The non-completers, however, differed
slightly in age [68.1 (11.1) years, P ¼ 0.03], gait speed [1.1 (0.2) m/s,
P¼ 0.002], peak KFM [1.78 (0.78) % body weight*height, P¼ 0.001],
and knee pain severity [11.74 (7.76), P ¼ 0.02].
Table I provides themean baseline peak KAM, KAM impulse, and
peak KFM for knees without vs with baseline-to-2-year cartilage
damage progression, and for knees without vs with bone marrow
lesion progression. Table II shows the pairwise Spearman
Table I
Peak KAM, KAM impulse, and peak KFM at baseline in knees without and with semiquantitative cartilage damage progression and bone marrow lesion progression, mean (SD)
(n ¼ 391 knees from 204 persons)
Cartilage damage progression at 2-year follow-up Bone marrow lesion progression at 2-year follow-up
Medial tibiofemoral
compartment
61/391 (15.6%)*
Medial femoral
surface 48/391
(12.3%)
Medial tibial
surface 29/391
(7.4%)
Medial tibiofemoral
compartment 87/391
(22.3%)
Medial femoral
surface 53/391
(13.6%)
Medial tibial
surface 48/391
(12.3%)
Peak KAM
(% body wt*ht)
Knees without progression 1.66 (0.87) 1.67 (0.86) 1.65 (0.86) 1.59 (0.86) 1.65 (0.87) 1.60 (0.85)
Knees with progression 1.70 (0.77) 1.68 (0.81) 1.83 (0.76) 1.92 (0.77) 1.77 (0.73) 2.15 (0.71)
KAM impulse
(s*% body wt*ht)
Knees without progression 0.60 (0.43) 0.60 (0.43) 0.59 (0.43) 0.55 (0.42) 0.59 (0.44) 0.56 (0.42)
Knees with progression 0.64 (0.50) 0.64 (0.51) 0.73 (0.51) 0.79 (0.47) 0.70 (0.43) 0.92 (0.45)
Peak KFM
(% body wt*ht)
Knees without progression 2.11 (0.86) 2.10 (0.86) 2.10 (0.86) 2.08 (0.89) 2.09 (0.88) 2.10 (0.87)
Knees with progression 1.98 (0.80) 2.01 (0.81) 1.98 (0.84) 2.13 (0.74) 2.15 (0.71) 2.08 (0.78)
* Percentage of knees (%) with 2-year progression.
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KAM impulse were highly correlated with each other and were
each highly correlated with varus alignment. Because of this, and
because it very likely falls in the casual KAM/disease progression
pathway, varus alignment was not a covariable for inclusion in
multivariablemodels. As in Table III, greater baseline peak KAMwas
signiﬁcantly associated with bonemarrow lesion progression at the
medial tibial surface, and KAM impulse with bone marrow lesion
progression in the medial tibiofemoral compartment and specif-
ically at the tibial surface. There was no evidence of an association
between baseline peak KAM or KAM impulse and cartilage damage
progression (Table III). Baseline peak KFM was not associated with
cartilage damage (e.g., for medial tibiofemoral compartment,
adjusted OR 0.96, 95% CI: 0.65, 1.42) or bone marrow lesion pro-
gression (e.g., for medial tibiofemoral compartment, adjusted OR
1.19, 95% CI: 0.90, 1.58).
In the assessment of cartilage thickness change, six additional
knees were excluded due to image technical problems, leaving 385
knees for analysis. As in Table IV, greater baseline peak KAM and
KAM impulse were each signiﬁcantly associated with greater
baseline-to-2-year % cartilage thickness loss as a continuous vari-
able, at the medial tibial surface, external and central tibial sub-
regions, central femoral weightbearing surface, and central femoral
subregion. Table V shows mean baseline peak KAM, KAM impulse,
and peak KFM among knees without and with 5% cartilage
thickness loss. In analyses of the secondary outcome, KAM impulse
was signiﬁcantly associated with5% cartilage thickness loss at the
medial tibial surface (adjusted OR 2.39, 95% CI: 1.28, 4.48) and
medial central weightbearing femoral surface (adjusted OR 2.88,
95% CI: 1.66, 5.00) and each subregion evaluated. There was no
signiﬁcant association between peak KAM and this outcome at any
surface or subregion (data not shown). There were no association
between baseline KFM and subsequent cartilage thickness loss by
either measure of cartilage thickness loss outcome (e.g., adjusted
regression coefﬁcient for continuous outcome 0.18, 95% CI: 0.71,Table II
Spearman correlations for pairs of continuous variables at baseline (n ¼ 197 right knees
Age K/L grade Knee alignment
(varus is negative
Age 1.00 0.17 0.12
K/L grade 1.00 0.12
Knee alignment
(varus is negative)
1.00
Gait speed
KAM
KAM impulse
KFM1.08 at the medial tibial surface and 0.65, 95% CI: 0.86, 2.17 at the
medial central weightbearing femoral surface).
As illustrated in Fig. 1, non-normalized KAM parameters corre-
lated strongly with normalized values. In sensitivity analyses, the
non-normalized values of the KAM parameter yielded a pattern of
results similar to ﬁndings using the normalized values.Discussion
Greater baseline peak KAM and KAM impulse were each asso-
ciated with baseline-to-2-year worsening of medial tibiofemoral
bone marrow lesions, but not cartilage damage assessed semi-
quantitatively. Higher baseline KAM impulse was associated with
2-year medial cartilage thickness loss assessed both as % loss and
deﬁned as a threshold of loss exceeding measurement error,
whereas peak KAMwas related only to % loss.We found evidence of
a KAM/cartilage thickness loss relationship in the external and
central subregions of the medial femoral and tibial surfaces. In
contrast, there was no evidence of an association between baseline
peak KFM and any disease progression outcomes.
In a previous longitudinal study of 74 hospital patients with
medial knee OA, the risk of baseline-to-6-year radiographic medial
OA progression, deﬁned as at least one grade worsening of medial
joint space width, increased by six fold with every 1-unit (i.e., 1%
BW  HT) increase in baseline peak KAM11. Analysis of a subset of
144 participants pooled from both the interventional and control
groups in a 12-month randomized controlled trial of wedge insoles
showed that baseline KAM impulse, but not peak KAM, was asso-
ciated with greater medial tibial cartilage volume loss over 12
months12. There was no association between KAM parameters and
12-month progression of semi-quantitative measures, i.e., medial
tibiofemoral cartilage defects or bone marrow lesions12. Recently,
in 16 individuals withmedial knee OA, baseline KAM and KFMwere
associated with 5-year change in femoral and tibial medial-to-
lateral cartilage thickness ratio13.)
)
Gait speed KAM KAM impulse KFM
0.18 0.02 0.02 0.11
0.15 0.08 0.15 0.09
0.03 0.71 0.76 0.23
1.00 0.10 0.06 0.44
1.00 0.95 0.15
1.00 0.05
1.00
Table III
Association of peak KAM and KAM impulse at baseline with semiquantitative medial tibiofemoral 2-year outcomes: adjusted ORs (95% CI) (n ¼ 391 knees from 204 persons)
Baseline predictor
variable
Cartilage damage progression Bone marrow lesion progression
Medial tibiofemoral
compartment 61/391 (15.6%)
Medial femoral surface
48/391 (12.3%)
Medial tibial
surface 29/391
(7.4%)
Medial tibiofemoral
compartment 87/391
(22.3%)
Medial femoral
surface 53/391
(13.6%)
Medial tibial
surface 48/391
(12.3%)
Peak KAM
(% body wt*ht)
0.98 (0.71, 1.34) 0.97 (0.68, 1.37) 1.18 (0.82, 1.72) 1.29 (0.95, 1.74) 1.04 (0.81, 1.35) 1.52 (1.09, 2.12)
KAM impulse
(s*% body wt*ht)
0.96 (0.53, 1.73) 0.95 (0.50, 1.81) 1.41 (0.59, 3.36) 2.20 (1.12, 4.38) 1.30 (0.80, 2.12) 3.29 (1.46, 7.41)
The table shows the association between peak KAM and KAM impulse at baseline (independent variables) and medial tibiofemoral cartilage damage progression and bone
marrow lesion progression 2-year outcomes (dependent variables, each deﬁned by any worsening of subregionWORMS score), adjusted for gait speed, age, gender, K/L grade,
knee pain severity, and medication use. Adjusted ORs and 95% CI are presented; 95% CI excluding 1 is signiﬁcant (shown in bold fonts).
Table IV
Association of peak KAM and KAM impulse at baseline with 2-year quantitative medial tibiofemoral cartilage thickness loss (% loss): adjusted regression coefﬁcients (95% CI)
(n ¼ 385 knees from 203 persons)
Baseline predictor
variable
% Cartilage thickness loss (n ¼ 385)
Medial tibial surface Medial central weightbearing femoral surface
Whole (n ¼ 385) Central subregion
(n ¼ 384)
External subregion
(n ¼ 378)
Posterior subregion
(n ¼ 385)
Whole (n ¼ 384) Central subregion
(n ¼ 380)
External subregion
(n ¼ 373)
Peak KAM
(% body wt*ht)
1.25 (0.03, 2.48) 2.50 (0.09, 4.91) 4.35 (0.65, 8.06) 0.88 (0.14, 1.91) 2.70 (0.18, 5.22) 4.42 (0.16, 8.67) 3.44 (17.95, 11.07)
KAM impulse
(s*% body wt*ht)
3.38 (1.33, 5.42) 6.25 (2.40, 10.10) 10.98 (5.02, 16.94) 2.07 (0.06, 4.20) 7.62 (4.15, 11.08) 12.16 (5.71, 18.61) 13.70 (60.50, 33.11)
The table shows the association between peak KAM and KAM impulse at baseline (independent variables) and 2-year cartilage thickness loss (dependent variable, % loss as a
continuous variable), adjusted for gait speed, age, gender, K/L grade, knee pain severity, and medication use. Adjusted regression coefﬁcients and 95% CI are presented; 95% CI
excluding 0 is signiﬁcant (shown in bold fonts).
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required for gait data acquisition and processing) cohort study
allowed adjustment for potential confounders that previous studies
were unable to fully address. Unlike prior studies, our cohort was
recruited predominantly from the community. We evaluated both
peak KAM and KAM impulse and semiquantitative and quantitative
outcomes. In some instances (medial TF BML progression; 5%
cartilage thickness loss at the medial tibial and femoral surfaces
and each subregion), KAM impulse, but not peak KAM, was
signiﬁcantly associated with the outcome. Integrating both load
magnitude and duration, KAM impulse maymore comprehensively
represent cumulative medial load experienced during gait than
peak KAM. Compared to peak KAM, KAM impulse has been shown
to be more sensitive in discriminating OA disease severity30 and
symptoms31, and a better predictor of medial-to-lateral ratio of
proximal tibial bone mineral density32. Our ﬁndings provide evi-
dence that KAM parameters should be a target in load-modifying
interventional trials for persons with medial knee OA.
Using a semi-quantitative approach, we found KAM parameters
were associated with bone marrow lesion but not cartilage damageTable V
Peak KAM, KAM impulse, and peak KFM at baseline in knees without andwith quantitative
knees from 203 persons)
Medial tibial surface
Whole
(74/385)
(19.2%)*
Central
subregion
(103/384) (26.8%)
Exte
subr
(93/
Peak KAM
(% body wt*ht)
Knees without progression 1.61 (0.82) 1.60 (0.82) 1.59
Knees with progression 1.91 (0.94) 1.85 (0.93) 1.84
KAM impulse
(s*% body wt*ht)
Knees without progression 0.55 (0.39) 0.55 (0.39) 0.54
Knees with progression 0.80 (0.56) 0.73 (0.54) 0.74
Peak KFM
(% body wt*ht)
Knees without progression 2.11 (0.87) 2.12 (0.89) 2.11
Knees with progression 2.01 (0.81) 2.03 (0.75) 2.07
* Proportion of knees (%) with 2-year progression.progression. Since baseline presence of bone marrow lesions pre-
dicted subsequent site-speciﬁc cartilage loss in persons at risk for or
with knee OA33e35, baseline-to-2-year worsening of bone marrow
lesion may be a harbinger for future cartilage damage progression.
Alternatively, it may require more than 2 years to detect an asso-
ciation with cartilage damage progression using this measure of
outcome. Normalized and non-normalized KAM parameters
strongly correlated and shared a similar pattern of signiﬁcant as-
sociations with the outcomes.
Contrary to our hypothesis and to a recent report13, therewas no
association between baseline peak KFM and any outcome 2 years
later. In recent years, the role of peak KFM during gait in medial
compartment knee contact load has received more attention.
Walter and colleagues14 showed that the effect of KAM reduction
by gait modiﬁcation did not necessarily guarantee a corresponding
decrease in peak medial knee load, likely due to a concurrent
deleterious increase of peak KFM. Medial knee load was suggested
to be best estimated by a combination of peak KAM and peak
KFM14,15,36. We did not ﬁnd a link between peak KFM and disease
progression, suggesting that a compensatory increase in KFMmedial cartilage thickness loss (5%) by surface and subregions, mean (SD) (n¼ 385
Medial central weightbearing femoral surface
rnal
egion
378) (24.6%)
Posterior
subregion
(74/385) (19.2%)
Whole
(103/384)
(26.8%)
Central
subregion
(124/380) (32.6%)
External
subregion
(98/373) (26.3%)
(0.82) 1.63 (0.83) 1.56 (0.81) 1.54 (0.83) 1.58 (0.83)
(0.91) 1.81 (0.93) 1.95 (0.92) 1.89 (0.85) 1.85 (0.89)
(0.39) 0.57 (0.40) 0.53 (0.38) 0.51 (0.38) 0.53 (0.39)
(0.53) 0.74 (0.56) 0.80 (0.53) 0.78 (0.50) 0.76 (0.52)
(0.89) 2.11 (0.88) 2.09 (0.87) 2.10 (0.87) 2.09 (0.85)
(0.77) 2.03 (0.76) 2.10 (0.82) 2.10 (0.84) 2.09 (0.88)
Fig. 1. Scatterplot of KAM impulse normalized to body weight and height (s*% body
wt*ht) vs non-normalized KAM impulse (Nm*s) in 197 right knees at baseline. The
Spearman correlation coefﬁcient for this association was 0.83 (P < 0.0001). For the
association between normalized and non-normalized peak KAM values, the correlation
coefﬁcient was 0.64 (P < 0.0001).
A.H. Chang et al. / Osteoarthritis and Cartilage 23 (2015) 1099e11061104associated with KAM reduction may not necessarily be deleterious
in the structural progression of knee OA. It is plausible that KAM is
more strongly associated with medial knee load and that the KFM
contribution is less important. Indeed, multivariable regression
models for medial knee load indicated that peak KAM had a much
greater relative effect on peak medial load than peak KFM14,36.
In the subregional analysis, KAM parameters were signiﬁcantly
associated with cartilage thickness loss in the medial tibial external
and central subregions and central femoral subregion, in keeping
with the concept that cartilage in these subregions is subject to
greater continuous load in the environment of greater KAM.
Although higher peak KFM during gait theoretically may impose
greater load on the posterior tibial subregion, our results did not
support a negative consequence for the cartilage by 2 years.
The interchangeable use of “KAM” and “medial knee load” has
been questioned in recent years14,15. To further clarify the rela-
tionship between KAM and instrumented-implant-measured
medial load in a larger sample, Kutzner and colleagues37 found
strong associations between KAM and medial load in early but not
in late stance, and that KAM was highly correlated with medial-to-
lateral load ratio throughout stance. In a single-subject interven-
tional case report, wearing a medial knee load-modifying variable-
stiffness intervention shoe during walking successfully reduced
both the ﬁrst peak KAM and peak medial knee load. KAM reduction
strongly predicted reduction in medial load measured in vivo38.
Ideally, load-modifying interventions should aim at reducing
medial load, not just KAM. Considering the invasive nature of
instrumented knee implants and inherent limitations in musculo-
skeletal models for predicting knee load, KAM may be a sensible
alternative. The link between KAM parameters and subsequent
disease progression demonstrated in our study conﬁrmed that
KAM, although only a determinant of medial knee load, is a
reasonable biomechanical target for disease-modifying
interventions.
There are several limitations in this study. Follow-up time
longer than 2 years may be needed to detect associations between
baseline KAM parameters and semi-quantitative cartilage damage
progression. Employing an alternative within-grade WORMS
scoring method may increase the sensitivity to longitudinal change
of cartilage damage39. Although KFM was not associated withdisease progression, alternative novel knee load indices, e.g., the
total knee reaction moment40,41, which represents the magnitude
of external knee moments in all three planes, may potentially
better capture medial knee load and predict disease progression.
Mean BMI of our sample was in the overweight range; results may
not be generalizable to a healthy-weight or obese population.
Lastly, our sample included knees predominantly with mild OA;
ﬁndings may differ in knees at a later stage of disease.
As the trajectory and experience of pain in knee OA often does
not correspond well to the trajectory of disease progression, future
studies should carefully evaluate this outcome. Both quantitative
and qualitative aspects of physical activity are important in further
understanding the association between KAM and disease pro-
gression knee OA. The role of physical activity in the KAM-disease
progression relationship should be evaluated in future studies.
In conclusion, in persons with knee OA, greater baseline peak
KAM and KAM impulse were each associated with baseline-to-2-
year worsening of medial tibiofemoral bone marrow lesions but
not cartilage damage assessed semi-quantitatively. Higher baseline
KAM impulse predicted 2-year medial cartilage thickness loss
assessed quantitatively both as percent loss and as loss deﬁned by a
threshold, whereas peak KAM was related to medial cartilage loss
only as % loss. There was no evidence of a relationship between
baseline peak KFM and any measure of progression. These ﬁndings
support targeting KAM parameters in an effort to delay medial OA
disease progression.
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